Skip to main navigation
Skip to search
Skip to main content
The Australian National University Home
Help & FAQ
Home
Profiles
Research output
Projects
Research units
Search by expertise, name or affiliation
Rituximab in autoimmune diseases
Katrina L. Randall
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
69
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rituximab in autoimmune diseases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Rituximab
100%
Autoimmune Disease
100%
Infection
25%
Randomized Controlled Trial
25%
B Cell
25%
Rheumatoid Arthritis
25%
Monoclonal Antibody
25%
ANCA Associated Vasculitis
25%
Granulomatosis with Polyangiitis
25%
Contraindication
25%
Pharmacology, Toxicology and Pharmaceutical Science
Autoimmune Disease
100%
Rituximab
100%
Infection
25%
Rheumatoid Arthritis
25%
Randomized Controlled Trial
25%
Monoclonal Antibody
25%
ANCA Associated Vasculitis
25%
Wegener Granulomatosis
25%
Immunology and Microbiology
Autoimmune Disease
100%
Rituximab
100%
B Cell
25%
Inflammatory Arthritis
25%
Monoclonal Antibody
25%
ANCA Associated Vasculitis
25%
Granulomatosis with Polyangiitis
25%